1. Home
  2. ENTX vs AMWL Comparison

ENTX vs AMWL Comparison

Compare ENTX & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • AMWL
  • Stock Information
  • Founded
  • ENTX 2010
  • AMWL 2006
  • Country
  • ENTX Israel
  • AMWL United States
  • Employees
  • ENTX N/A
  • AMWL N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • AMWL Retail: Computer Software & Peripheral Equipment
  • Sector
  • ENTX Health Care
  • AMWL Technology
  • Exchange
  • ENTX Nasdaq
  • AMWL Nasdaq
  • Market Cap
  • ENTX 104.0M
  • AMWL 106.7M
  • IPO Year
  • ENTX 2018
  • AMWL 2020
  • Fundamental
  • Price
  • ENTX N/A
  • AMWL $8.51
  • Analyst Decision
  • ENTX Strong Buy
  • AMWL Hold
  • Analyst Count
  • ENTX 1
  • AMWL 7
  • Target Price
  • ENTX $10.00
  • AMWL $9.67
  • AVG Volume (30 Days)
  • ENTX 33.0K
  • AMWL 38.3K
  • Earning Date
  • ENTX 08-08-2025
  • AMWL 07-30-2025
  • Dividend Yield
  • ENTX N/A
  • AMWL N/A
  • EPS Growth
  • ENTX N/A
  • AMWL N/A
  • EPS
  • ENTX N/A
  • AMWL N/A
  • Revenue
  • ENTX $223,000.00
  • AMWL $261,675,000.00
  • Revenue This Year
  • ENTX N/A
  • AMWL $2.87
  • Revenue Next Year
  • ENTX N/A
  • AMWL $6.72
  • P/E Ratio
  • ENTX N/A
  • AMWL N/A
  • Revenue Growth
  • ENTX N/A
  • AMWL 2.79
  • 52 Week Low
  • ENTX $1.41
  • AMWL $5.90
  • 52 Week High
  • ENTX $2.79
  • AMWL $12.95
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 43.51
  • AMWL 65.14
  • Support Level
  • ENTX $1.84
  • AMWL $6.57
  • Resistance Level
  • ENTX $2.02
  • AMWL $9.15
  • Average True Range (ATR)
  • ENTX 0.14
  • AMWL 0.45
  • MACD
  • ENTX -0.01
  • AMWL 0.19
  • Stochastic Oscillator
  • ENTX 14.71
  • AMWL 75.24

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About AMWL American Well Corporation

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

Share on Social Networks: